Federated Hermes’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12M | Buy |
+277,587
| New | +$12M | 0.02% | 528 |
|
|
2024
Q3 | – | Sell |
-4,500
| Closed | -$114K | – | 2063 |
|
|
2024
Q2 | $114K | Sell |
4,500
-75,028
| -94% | -$1.9M | ﹤0.01% | 1552 |
|
|
2024
Q1 | $2.46M | Sell |
79,528
-367,643
| -82% | -$11.4M | 0.01% | 880 |
|
|
2023
Q4 | $18.1M | Sell |
447,171
-18,605
| -4% | -$751K | 0.04% | 413 |
|
|
2023
Q3 | $12.3M | Buy |
465,776
+31,855
| +7% | +$840K | 0.03% | 487 |
|
|
2023
Q2 | $7.46M | Buy |
433,921
+178,353
| +70% | +$3.07M | 0.02% | 607 |
|
|
2023
Q1 | $4.24M | Buy |
+255,568
| New | +$4.24M | 0.01% | 741 |
|
|
2019
Q3 | – | Sell |
-5,000
| Closed | -$135K | – | 2204 |
|
|
2019
Q2 | $135K | Buy |
+5,000
| New | +$135K | ﹤0.01% | 1580 |
|